Alteration of SMAD4 does not participate in tumorigenesis of adenoid cystic carcinoma of the salivary gland

Molecular Medicine Reports

Volumn 2, Issue 1, 2009, Pages 13-15

  Daa, Tsutomu ^a   Yada, Naomi ^a   Kashima, Kenji ^a   Suzuki, Masashi ^a   Yokoyama, Shigeo ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Adenoid cystic carcinoma; SMAD; TGF signaling

Indexed keywords

SMAD4 PROTEIN;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; SALIVARY GLAND CARCINOMA; TUMOR PROMOTION;

EID: 69249094997     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000054     Document Type: Article

References (21)

1. Hahn SA, Hoque AT, Moskaluk CA, et al: Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56: 490-494, 1996.
2. Hahn SA, Schutte M, Hoque AT, et al: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353, 1996.
3. Schutte M: DPC4/SMAD4 gene alterations in human cancer, and their functional implications. Ann Oncol 10: 56-59, 1999.
4. Hata A: TGFβ signaling and cancer. Exp Cell Res 264: 111-116, 2001.
5. Howe JR, Roth S, Ringold JC, et al: Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280: 1086-1088, 1998.
6. Miyaki M, Iijima T, Konishi M, et al: Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18: 3098-3103, 1999.
7. Ellis GL and Auclair PL: Adenoid cystic carcinoma. In: Atlas of Tumor Pathology Tumors of the Salivary Glands. Rosai J (ed). Armed Forces Institute of Pathology, Washington DC, pp203-216, 1996
8. Rosai J (ed): Major and minor salivary gland. In: Rosai and Ackerman's Surgical Pathology. MOSBY, New York, pp892-894, 2004
9. Papadaki H, Finkelstein SD, Kounelis S, Bakker A, Swalsky PA and Kapadia SB: The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma. Hum Pathol 27: 567-572, 1996. (Pubitemid 26187280)
10. Kiyoshima T, Shima K, Kobayashi I, et al: Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 37: 315-322, 2001. (Pubitemid 32245858)
11. Holst VA, Marshall CE, Moskaluk CA and Frierson HF Jr: KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 12: 956-960, 1999.
12. Shintani S, Funayama T, Yoshihama Y, et al: Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study. Anticancer Res 15: 2623-2626, 1995.
13. Kim IY, Kim MM and Kim SJ: Transforming growth factor-β: biology and clinical relevance. J Biochem Mol Biol 38: 1-8, 2005. (Pubitemid 43025971)
14. Elliott RL and Blobe GC: Role of transforming growth factor Beta in human cancer. J Clin Oncol 23: 2078-2093, 2005. (Pubitemid 46211385)
15. Shi Y, Hata A, Lo RS, Massague J and Pavletich NP: A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388: 87-93, 1997. (Pubitemid 27283894)
16. Liu F, Pouponnot C and Massague J: Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes. Genes Dev 11: 3157-3167, 1997. (Pubitemid 27528056)
17. Miyaki M and Kuroki T: Role of Smad4 (DPC4) inactivation in human cancer. Biochem Biophys Res Commun 306: 799-804, 2003. (Pubitemid 36776201)
18. Rozenblum E, Schutte M, Goggins M, et al: Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57: 1731-1734, 1997.
19. Bartsch D, Hahn SA, Danichevski KD, et al: Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene 18: 2367-2371, 1999.
20. Schutte M, Hruban RH, Hedrick L, et al: DPC4 gene in various tumor types. Cancer Res 56: 2527-2530, 1996.
21. MacGrogan D, Pegram M, Slamon D and Bookstein R: Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15: 1111-1114, 1997.